Atlas FDA

QDOT MICRO™ System

FDA premarket approval P210027/S012 · decided 2025-04-08

Approval details

PMA number
P210027
Supplement
S012
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
QDOT MICRO™ System
Generic name
Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
Applicant
Biosense Webster, Inc.
Date received
2024-07-24
Decision date
2025-04-08
Days to decision
258 days
Decision code
APPR
Product code
OAE
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
PAS protocol changes to retrospectively consent patients enrolled in REAL-AF Sites and to include the Zero/Low Fluoro Workflow.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CARTO™ 3 EP Navigation System V8.4 (K252972)Biosense Webster, Inc.2026-02-20
CARTO™ 3 EP Navigation System V9.0 with PIU Plus (K254085)Biosense Webster, Inc.2026-01-18
CARTO™ 3 EP Navigation System V8.1 (K252302)Biosense Webster, Inc.2025-08-22
NUVISION™ Ultrasound Catheter; NUVISION™ NAV Ultrasound Catheter (K241540)Biosense Webster, Inc.2024-06-28
SOUNDSTAR™ CRYSTAL Ultrasound Catheter (K240050)Biosense Webster, Inc.2024-06-12
CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U) (K231207)Biosense Webster, Inc.2023-09-07
PENTARAY® NAV ECO High Density Mapping Catheter, DECANAV® Mapping Catheter, Webster® CS Catheter with Auto ID, Webster® CS Catheter with EZ Steer Technology, Webster® CS Catheter with EZ Steer Technology with Auto ID (K231312)Biosense Webster, Inc.2023-07-10
CARTO VIZIGO® 8.5F Bi-Directional Guiding Sheath (D-1385-01-S, D-1385-02-S, D-1385-03-S) (K231412)Biosense Webster, Inc.2023-07-10